In compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Rallis India has informed that Padmini Khare Kaicker (DIN: 00296388) and Dr. C. V. Natraj (DIN: 07132764) have completed their second consecutive term as Independent Directors of the Company on July 21, 2026, and consequently ceased to be Independent Directors of the Company effective July 22, 2026. The brief details of the aforesaid changes as prescribed under SEBI Listing Regulations read with SEBI circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed as Annexure. This is also being made available on the website of the Company at www.rallis.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| UPL | 602.10 |
| PI Industries | 2731.25 |
| Bayer CropScience | 4218.45 |
| Sharda Cropchem | 872.90 |
| Sumitomo Chem. India | 520.10 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: